Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic, ...

Collectively, the data from in vitro and in vivo studies using FUS, TDP-43, and C9orf72 models demonstrate that hUPF1 holds significant potential for treating the majority of patients with ALS and ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 6 undervalued stocks in the Pharmaceuticals industry for Tuesday, May 13, 2025. Let’s take ...

Live human brain slices show that only a razor‑thin balance of amyloid beta keeps synapses safe. Any disruption, even slight, ...

Inovio Pharmaceuticals, Inc. ( NASDAQ: INO) Q1 2025 Earnings Conference Call May 13, 2025 4:30 PM ET Jennie Willson - IR Jacqui Shea - President & CEO Mike Sumner - Chief Medical Officer Steve Egge - ...

Horizon Kinetics' Q1 2025 commentary explores AI-driven data center demand, inflationary trends, and portfolio positioning.

Researchers at the Terasaki Institute for Biomedical Innovation (TIBI) have developed a technique that could help advance ...

Researchers at the Terasaki Institute for Biomedical Innovation (TIBI) have developed a technique that could help advance ...

Since U Been Gone' singer Kelly Clarkson has insisted she doesn't mind people complimenting her body after putting in the ...